Sentences with phrase «more care at»

Medical expenses tend to rise sharply throughout retirement as we grow older and require more care at higher prices.

People will have more care at the end of life.

Not exact matches

One accounting puts the number of AI startups in health care, where I compete, at more than 100.

I think that health care is now coming back, at least if you view health care broadly to include more capital - efficient and predictable parts of health care, like health care tech and services.

Nonetheless, expect to see less place for every day items at CVS stores eventually and more room for the higher value health care services, a move telegraphed by the company in 2014, when it changed its name from CVS Caremark to CVS Health.

Panelists at Fortune's Brainstorm Health conference weigh the merits of a more globalized health care system.

An event needs to take place at a specific time on a specific day, whereas another type of to - do, such as a follow - up call with a networking contact, can be taken care of on a more flexible schedule.

Many people prefer the option of their child being cared for in a home environment while they are at work, opposed to a more institutional - like setting.

I didn't much care that the SUV was favoring its rear wheels; I wanted more personality at 30 - 40 mph.

With the Conservatives in power, there really is much more of a belief that health care should really be just left to the provinces, and the extent to which the feds are involved if at all is really to support the Canada Health Act through the transfer of funding, but not really to look at whether or not [the act] is actually being fulfilled.

And nothing illustrates the problem more vividly than the picture of patients forced to wait weeks upon weeks for care that, at these prices, should be available practically the same day the patient calls.

At the same time, college costs have, according to published reports, increased 1,225 percent since 1978 (that is not a typo)-- more than housing, food or health - care expenses.

They might only get 95 percent quality instead of 100 percent, and it might cost 200 percent more, but who cares: They're growing at 963 percent a year!

Another shift is that employers are looking at performance - based networks to try to gain more affordable, efficient care.»

Another driving the higher prices: More buyers are choosing to bundle at - home care and nursing home care together, rather than simply pay for one or the other.

As these companies scaled I started realizing that, at a macro level, end consumers were starting to care less and less about who was delivering the information, and more about what the information was about.

Panoramic Resources and Mincor Resources have announced plans to put their last operating mines on care and maintenance in response to the depressed nickel market, with Panoramic cutting 50 jobs today with more to follow at both companies.

Competition: Established nonprofit agencies focused on at - home care have a competitive edge over new companies, as their brands have more name recognition and trust.

In peer countries like Canada, some citizens are taxed at higher rates throughout the year, the Organization for Economic Cooperation and Development notes, but they get a lot more from their government in terms of social services, including health care.

Because these bare - bones plans do not limit insurance payouts to workers, they meet the letter of the law's requirements that employers provide «affordable» health care coverage to their workers at a far lower cost than more comprehensive plans.

As a result, they grow up to do more care - taking than their peers raised by stay - at - home moms, and (slightly) more housework.

But if you care to take a more optimistic view, these responses suggest that there is an opportunity to unleash a ton of potential at any time if investors had the smarts.

The more effective approach is to reward employees with something they care about, and create moments that an employee will tie back to a specific achievement at their company.

Gardner says that while he can't confirm those numbers, «the ministry is being much more disciplined at controlling the envelope of costs that's going to [health - care] providers.»

But delivering the kind of personalized care Bridgepoint — and to perhaps a lesser degree, the province's Action Plan — calls for can actually be more expensive, at least up front, says Dr. Elaine Chin.

At the meeting in late 2016, executives said Quidsi would also generate significant free cash flow in 2017, which is notable because Amazon CEO Jeff Bezos has long said that he cares more about free cash flow than he does profit margins or profitability metrics such as operating income and net income.

«Now is the time to invest in, care for, protect, and empower our aging population so they can live more independent lives,» said Arvind Krishna, Senior Vice President at IBM Research, in a statement.

«Those models are actually letting consumers access care more quickly and at a lower cost,» says Joel White, president of the Council for Affordable Health Coverage.

«Long - term - care insurance is more like health insurance, and those prices are going up,» said Aaron Ball, senior vice president for long - term - care insurance products at Genworth.

More insurers are covering telemedicine services in 2016, which also allow consumers to access health care 24/7 from home, without the inconvenience of visiting a doctor and at a fraction of the price.

But the breakthroughs in health - tech — advances that, in theory at least, should make essential care more accessible to and cheaper for both consumers and providers — is only part of the transformation now underway.

Any startup that can help health care providers gain more insight into patients» conditions or behaviors is going to at least get a look from even the best and biggest of hospital systems.

«At the same time, we've learned a lot from our customers, in terms of care, and empathy and service, and we plan to bring these lessons to larger and larger businesses, as well as more small and medium enterprises, over time.

«I'm more at ease taking care of my own money than doing nothing and leaving it all to the government,» she added.

«A significant expansion of the Child Tax Credit will help parents have more money at a time in their lives when they need it the most and give them the flexibility to make the best choices regarding their families» care,» Ivanka said in a statement late last month.

Elaine Maag, a senior research associate at the Tax Policy Center, thinks that Ivanka's position likely changed as she became more educated on the issue and realized that the child tax credit reaches many more families than a child care credit could.

«If you look at some of the changes we've made recently, there is a bigger sense of being more engaged and taking care of customers.»

That business makes up a small percentage of the company's $ 67.4 billion in annual revenues, but Take Care Health is seeing more companies move to offer primary care services at their health centers, says Peter Hotz, Walgreen's group vice presidCare Health is seeing more companies move to offer primary care services at their health centers, says Peter Hotz, Walgreen's group vice presidcare services at their health centers, says Peter Hotz, Walgreen's group vice president.

To be sure, the full impact of the landmark health care law won't be felt for at least two more years.

The greater focus on executive pay means investors also care more about board pay, said Pat McGurn, head of strategic research and analysis at corporate governance firm ISS.

Ranking at No. 855 on the Inc. 5000, this health company offers peer review programs to more than 60 workers» compensation and managed - care organizations to assist in the claims management process.

The situation is pressuring U.S. hospitals to pay at least $ 230 million more a year than they ordinarily would to find alternative treatments, according to Michael Alkire, COO of Premier, an alliance of hospitals and health care providers.

And the prestigious Cleveland Clinic used the company's tools to identify the patients who were most at risk of potentially avoidable emergency - room admission, a step that enabled them to reach out to those patients proactively and provide them with care less expensively and more safely.

«This gives people more power to dig deeper into the topics they care about,» Zuckerberg said while discussing the makeover at Facebook's Menlo Park, California, headquarters.

For a recent study published in the Journal of the American College of Cardiology, researchers at the Harvard T.H. Chan School of Public Health analyzed the eating habits of more than 200,000 health care workers over the course of more than 20 years.

In January, three more corporate behemoths — Amazon (amzn), JPMorgan Chase (jpm), and Berkshire Hathaway (brk - a)-- said they were forming a joint venture aimed at reducing health care costs and improving outcomes for their combined 1 million or so employees.

To see what the new balance of power will look like in the coming years — and what it looks like right now — Fortune interviewed more than three dozen executives at companies across the health care continuum, along with entrepreneurs, doctors, patients, and other experts.

Also under threat may be another measure to usher in more detailed labeling requirements for menus at restaurants and grocery stores, which passed as part of the 2010 health overhaul known as the Affordable Care Act or Obamacare.

That's happening at the same time that the Canadian population is getting older, meaning there will be more Canadians in need of care.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).